Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling
Jason M. D’Antonio(Johns Hopkins University), John T. Isaacs(Brady (Norway))
Cited by 37
Related Papers
The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells
|Cancer Research|2008|233
Is the Achilles’ Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?
|The Journal of Clinical Endocrinology & Metabolism|2003|211